Clinical significance of antinuclear antibody positivity in patients with severe coronavirus disease 2019
Soo Hyun Park, Jin Woong Suh, Kyung-Sook Yang, Jeong Yeon Kim, Sun Bean Kim, Jang Wook Sohn, Young Kyung Yoon
Korean J Intern Med. 2023;38(3):417-426. Published online 2023 Apr 6 DOI: https://doi.org/10.3904/kjim.2022.352
Citations to this article as recorded by 
Coronavirus disease 2019 (COVID-19) pandemic and autoimmune rheumatic diseases: Outcomes and prospects
E. L. Nasonov
Rheumatology Science and Practice.2024; 62(1): 32. CrossRef
The Onset of Antinuclear Antibodies (ANAs) as a Potential Risk Factor for Mortality and Morbidity in COVID-19 Patients: A Single-Center Retrospective Study
Giuseppe Stefano Netti, Piera Soccio, Valeria Catalano, Federica De Luca, Javeria Khalid, Valentina Camporeale, Giorgia Moriondo, Massimo Papale, Giulia Scioscia, Gaetano Corso, Maria Pia Foschino, Sergio Lo Caputo, Donato Lacedonia, Elena Ranieri
Biomedicines.2024; 12(6): 1306. CrossRef
Association Between SARS-CoV-2 Vaccination and Development of Antinuclear Antibodies Among Students
Karol Laskowski, Justyna Paszkiewicz, Dorota Plewik, Adam Szepeluk, Kamil K. Hozyasz
Journal of Primary Care & Community Health.2024;[Epub] CrossRef
Clinical and immunologic abnormalities in COVID-19
A. K. Karibova, S. S. Akhmedkhanov, M. T. Kudae, H. M. Malaev
Modern Rheumatology Journal.2024; 18(5): 90. CrossRef
Significance of antinuclear antibodies in patients with COVID-19
Oh-Hyun Cho
The Korean Journal of Internal Medicine.2023; 38(3): 280. CrossRef
Modern concept of autoimmunity in rheumatology
E. L. Nasonov
Rheumatology Science and Practice.2023; 61(4): 397. CrossRef